Showing posts with label life sciences. Show all posts
Showing posts with label life sciences. Show all posts

Saturday, April 25, 2026

'Too Dangerous to Release' Is Becoming AI's New Normal; Time, April 24, 2026

Nikita Ostrovsky, Time; 'Too Dangerous to Release' Is Becoming AI's New Normal

 "On April 16, OpenAI announced GPT-Rosalind, a new AI model targeted at the life sciences. It significantly outperforms their current publicly available models in chemistry and biology tasks, as well as experimental design. As with Anthropic’s Claude Mythos and OpenAI’s GPT-5.4-Cyber, also released this month, the model is not available to the general public—reserved, at least initially, for “qualified customers” through a “trusted access program.” 

The releases signal a new and concerning trend of AI companies deeming their most capable models too powerful to entrust to the general public. “I think frontier developers are restricting access to their most capable models because they are genuinely worried about some of the capabilities these models have,” says Peter Wildeford, head of policy at the AI Policy Network, an advocacy group. 

It is unclear why OpenAI decided to restrict access to GPT-Rosalind in particular. An OpenAI spokesperson said in an email that giving access to trusted partners allows the company to “make more capable systems available sooner to verified users, while still managing risk thoughtfully.”

Who decides? 

The rapid advance of AI capabilities raises the question of whether private companies should be making the increasingly weighty decisions about whether and how potentially dangerous AI models should be built, and who should be allowed to use them."

Thursday, November 14, 2019

AI and gene-editing pioneers to discuss ethics at Stanford; Stanford News, November 12, 2019

Ker Than, Stanford News; AI and gene-editing pioneers to discuss ethics at Stanford

"Upon meeting for the first time at a dinner at Stanford earlier this year, Fei-Fei Li and Jennifer Doudna couldn’t help but note the remarkable parallels in their experiences as scientists.

Both women helped kickstart twin revolutions that are profoundly reshaping society in the 21st century – Li in the field of artificial intelligence (AI) and Doudna in the life sciences. Both revolutions can be traced back to 2012, the year that computer scientists collectively recognized the power of Li’s approach to training computer vision algorithms and that Doudna drew attention to a new gene-editing tool known as CRISPR-Cas9 (“CRISPR” for short). Both pioneering scientists are also driven by a growing urgency to raise awareness about the ethical dangers of the technologies they helped create."